A clinical trial (#NCT04295759, https://clinicaltrials.gov/ (accessed on 17 October 2022)) is underway to test the efficacy of the medication INCB7839 in inhibiting ADAM10 in gliomas. The gene discussed is ADAM10; the disease is central nervous system cancer.